St. Jude Family of Websites
Explore our cutting edge research, world-class patient care, career opportunities and more.
St. Jude Children's Research Hospital Home
Also called: Biallelic mismatch repair deficiency syndrome (BMMRD)
Constitutional mismatch repair deficiency syndrome (CMMRD) is a rare genetic disorder that makes a child more likely to develop:
A child with this syndrome can develop more than 1 type of cancer at a time. They also can develop more than 1 type of cancer during their lifetime.
The exact risk of developing cancer for people with this syndrome is not known. The risk for cancer is expected to be high. CMMRD can cause a variety of cancers. It is hard to predict what type of cancer a child may develop and when that cancer will occur.
Genes carry information telling cells in the body how to function. CMMRD is related to changes in the genes MLH1, MSH2, MSH6, or PMS2. It can sometimes be related to a gene called EPCAM, but this is rare.
The MLH1, MSH2, MSH6, and PMS2 genes help repair a type of DNA damage through a process called “mismatch repair” or MMR. It is harder for people with CMMRD to repair the damage that naturally happens in their genes. This can lead to polyps and tumors in young children.
Most people have 2 working copies of each of the MMR genes in their cells. They inherit 1 copy from their mother and 1 copy from their father. A gene change that causes the gene to not work properly is called a mutation.
When someone inherits an MMR gene mutation from their mother and another mutation in the same MMR gene from their father, they have CMMRD. This person has a mutation that affects each of the 2 copies of an MMR gene.
Most children with this syndrome inherit the MMR gene mutations from their parents. Parents of a child with this syndrome have a 25% or 1 in 4 chance each pregnancy of having a child with the same syndrome.
All children of a parent with CMMRD will inherit 1 MMR mutation. Lynch syndrome is a condition where people have 1 MMR gene mutation. The partner of a person with Lynch syndrome might consider genetic testing to see if they also carry an MMR gene mutation. This can help determine risks of having a child with CMMRD.
A person with 1 working copy and 1 non-working copy of a mismatch repair (MMR) gene has a condition known as hereditary non-polyposis colorectal cancer (Lynch syndrome). When a child has constitutional mismatch repair deficiency, it is likely that both parents have Lynch syndrome.
People with Lynch syndrome are more likely to develop certain types of cancer, such as colon, uterine, ovarian, and small bowel cancer. They develop these most often as adults.
It is important that those with Lynch syndrome have routine health care visits and screenings. It may be best to find a gastroenterologist who knows the condition well.
If you have Lynch syndrome, talk with your primary care provider about suggested cancer screenings:
A health care provider may suspect that your child has CMMRD after studying their medical and family history.
This information helps the health care provider and the genetic counselor know if:
Health care providers or genetic counselors may recommend genetic testing of the MMR genes if they suspect CMMRD. Learn more about types of genetic testing.
A blood sample is sent to a genetic testing lab. The lab runs genetic tests that looks for changes in the MLH1, MSH2, MSH6, PMS2, and/or EPCAM genes.
If your child has a gene mutation, the genetic counselor will work with your family to:
Parents may choose to do prenatal testing to find out if a pregnancy is affected with known MMR mutations. Testing may take place either before pregnancy occurs or during pregnancy.
You should work with a genetic counselor to review the pros and cons of the test. The genetic counselor can also help you prepare for the test results.
Testing before pregnancy is called preimplantation genetic testing (PGT). This special type of genetic testing is done along with in vitro fertilization (IVF). PGT tests embryos for known MMR mutations before a provider places them into the uterus.
Testing during pregnancy can help providers see if a pregnancy is affected with known MMR mutations. A doctor gathers cells from the pregnancy in 1 of 2 ways:
After tissue collection, the lab checks the sample for MMR mutations. Both tests carry minor risks. Discuss risks with an experienced health care provider or genetic counselor.
Take time to consider the benefits and risks. Speak with a genetic counselor before testing. If you decide to get tested, review the results with the health care provider or genetic counselor so you can understand what they mean.
It is normal to feel sad, anxious, or angry after learning about genetic mutations. Parents who pass on MMR mutations to 1 or more of their children may feel guilty. People with MMR mutations may have trouble getting disability coverage, life insurance, or long-term care insurance in some states.
Read more about genetic discrimination.
Children with CMMRD are at risk of developing multiple types of cancer during their life. It is important to monitor children’s health and help them adopt healthy habits. They need to have regular physical checkups and screenings. This way, the care team can find cancer early at the most treatable stage.
Cancer screening for those with CMMRD
Discuss tumor screening tests with a health care provider who knows this syndrome well.
Screening tests may include:
It is possible that recommended screenings may change over time as health care providers learn more about CMMRD. People with CMMRD should discuss all screening options with a health care provider who knows this condition well.
Watch closely for signs or symptoms that could signal cancer, such as:
Habits that will help you maintain a healthy lifestyle include:
The St. Jude Cancer Predisposition Program is dedicated to diagnosing and screening children with a genetic predisposition for cancer. Our program offers the best clinical care possible. We engage in cutting-edge research to gain more information about genetic disorders and cancer, and to improve the care and treatment for patients who are affected by these conditions. Learn more about the Division of Cancer Predisposition at St. Jude.
Our genetic counselors, clinicians, genetics nurse practitioners, and research assistants work together to provide patients with:
CMMRD increases your child’s risk for many types of cancer.
St. Jude offers clinical trials and cancer research studies for children, teens, and young adults who have cancers associated with CMMRD. See diseases treated at St. Jude.
Learn more about clinical research at St. Jude.
Study goal:
To learn more about participants beliefs, attitudes, and questions about gene therapy to help make web-based resources to share information. This could help patients make treatment decisions.
Age:
18 to 35 years old with rare genetic diseases
Study goal:
The main goal of this study is to learn more about the reasons childhood tumors form and how to treat them better.
Study goal:
To provide a high-quality repository of tumor and normal samples to facilitate translational research performed by St Jude faculty and their collaborators
Study goal:
1) Test each patient for hundreds of gene variations that might be important for drug use. All of the gene test results will be in the research laboratory, but as time goes on, the study will evaluate scientific evidence and selectively move test results for a few genes into the medical record if the evidence strongly shows that the result can help in better prescribing of drugs for patients; 2) Estimate how often pharmacogenetic test results are moved from research tests into a patient’s medical record; 3) Use methods to choose which of these tests should be put in the medical record; 4) Use computer-based tools in the electronic medical record to help doctors use gene test results when prescribing drugs; 5) Share feelings and concerns of patients and their families about gene test information being put in their medical record.
Study goal:
The main purpose of this trial is to learn about the genetic causes of cancer.
Age:
Younger than 50 years old
Study goal:
To collect data about how Friedreich’s ataxia progresses over time and affects the daily life of patients.
Age:
Any
Patients accepted to St. Jude must have a disease we treat and must be referred by a physician or other qualified medical professional. We accept most patients based on their ability to enroll in an open clinical trial.
Call: 1-888-226-4343 (toll-free) or 901-595-4055 (local) | Fax: 901-595-4011 | Email: referralinfo@stjude.org | 24-hour pager: 1-800-349-4334
If you have questions about the Genetic Predisposition Clinic and care for CMMRD, email our team at GPTeam@stjude.org.